BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3683924)

  • 1. [Follow-up of colorectal neoplasms: use of TPA].
    Citone G; Catani M; Procacciante F; Perri S; Pronio A; Ribotta G
    Minerva Chir; 1987 Oct; 42(20):1625-6. PubMed ID: 3683924
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preoperative determination of TPA in colorectal neoplasms. Evaluation of a group consisting of 75 patients].
    Ramella A; Bussone R; Sanlorenzo M; Natta F; Caldarola B; Schirripa C; Giani R; Pecchio F; Rocca N
    Minerva Chir; 1987 Jul; 42(13-14):1181-4. PubMed ID: 3670651
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical study on tissue polypeptide antigen (TPA) as a tumor marker].
    Kanauchi M; Sawai F; Saito T; Yumura F; Kanauchi K; Hamaguchi T; Hara Y; Yoshimura K; Nishiura K; Dohi K
    Gan No Rinsho; 1984 Mar; 30(3):265-71. PubMed ID: 6201629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in both CEA and CA19-9 in sera is an independent prognostic indicator in colorectal carcinoma.
    Nozoe T; Rikimaru T; Mori E; Okuyama T; Takahashi I
    J Surg Oncol; 2006 Aug; 94(2):132-7. PubMed ID: 16847905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of tumour markers (CEA, TPA, CA 19-9) in colon and rectum carcinomas.
    Cangemi V; Volpino P; Fiori E; Giammarco A; Piat G
    J Nucl Med Allied Sci; 1987; 31(2):189-93. PubMed ID: 3476692
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
    Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
    J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of serum tissue polypeptide antigen (TPA) in patients with colo-rectal cancer].
    Yukawa H; Kono N; Taniguchi K; Ieda K; Ono K; Yamamoto S; Koh K; Ohta M; Hayashido M; Yamaguchi K
    Nihon Geka Hokan; 1984 Mar; 53(2):433-6. PubMed ID: 6508467
    [No Abstract]   [Full Text] [Related]  

  • 8. [Carcinoembryonic antigen, CEA, in colorectal cancer. An insensitive marker which may be excluded from follow-ups].
    Wählby L
    Lakartidningen; 1997 Apr; 94(18):1716-8. PubMed ID: 9182180
    [No Abstract]   [Full Text] [Related]  

  • 9. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer.
    Iizasa T; Suzuki M; Yoshida S; Motohashi S; Yasufuku K; Iyoda A; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T
    Ann Thorac Surg; 2006 Jul; 82(1):254-60. PubMed ID: 16798225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of serum CA 19-9 in patients with gastric and colorectal carcinoma and immunohistochemical visualization of CA 19-9 in tumor tissues.
    Sekikawa K
    Fukushima J Med Sci; 1985 Jun; 31(1):29-42. PubMed ID: 3866740
    [No Abstract]   [Full Text] [Related]  

  • 11. [Colorectal neoplasms: preoperative determination of GICA].
    Bussone R; Sanlorenzo M; Natta F; Rocca N; Caldarola B
    Minerva Chir; 1987 Oct; 42(20):1655-6. PubMed ID: 3479706
    [No Abstract]   [Full Text] [Related]  

  • 12. [Importance of CEA determination in colo-rectal neoplasms].
    Pezcoller C; Ricchi E; Briccoli A; Saviano MS; Ferrara F; De Palma M; Guernelli N
    Minerva Chir; 1984 Feb; 39(3):153-60. PubMed ID: 6728213
    [No Abstract]   [Full Text] [Related]  

  • 13. [Follow-ups after colorectal cancer].
    Wählby L
    Tidsskr Nor Laegeforen; 1998 Jun; 118(16):2541. PubMed ID: 9667137
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic value of tissue polypeptide antigen (TPA) plasma levels in patients with malignant salivary gland tumors.
    Tanany H; Ezz M; Yassin S
    Egypt Dent J; 1993 Jul; 39(3):505-6. PubMed ID: 9590978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of tumor markers for proliferation and apoptosis in predicting survival in colorectal cancer.
    Hilska M; Collan YU; O Laine VJ; Kössi J; Hirsimäki P; Laato M; Roberts PJ
    Dis Colon Rectum; 2005 Dec; 48(12):2197-208. PubMed ID: 16400510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
    Li M; Li JY; Zhao AL; Gu J
    Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited clinical significance of the serum tumour marker Ca 72-4 in colorectal cancer.
    Lindmark G; Kressner U; Bergström R; Glimelius B
    Anticancer Res; 1996; 16(2):895-8. PubMed ID: 8687147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of the determination of serum carbohydrate antigen 19-9 in patients with carcinoma of the stomach and colorectum].
    Hamazoe R; Yoshioka H; Furumoto T; Kanayama H; Shimizu N; Maeta M; Koga S
    Gan No Rinsho; 1985 Aug; 31(10):1287-92. PubMed ID: 3863968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of postoperative determination of CEA in carcinoma of the large intestine].
    Florianello F; Gorla C; Biraghi T; Caron R; Scortecci V
    Minerva Med; 1986 Apr; 77(18):739-41. PubMed ID: 3714087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoembryonic antigen in the diagnosis and follow-up of colorectal carcinoma.
    Kåresen R; Hertzberg J; Johannesen J; Thoresen BO; Orjasaeter H
    Am J Proctol Gastroenterol Colon Rectal Surg; 1980 Nov; 31(11):18-22. PubMed ID: 7212050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.